Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry
Author:
Funder
National Institutes of Health
National Cancer Institute
Breast Cancer Research Foundation
Publisher
Elsevier BV
Subject
Pathology and Forensic Medicine
Reference44 articles.
1. Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis;McCabe;J Natl Cancer Inst,2005
2. Single-cell quantitative HER2 measurement identifies heterogeneity and distinct subgroups within traditionally defined HER2-positive patients;Onsum;Am J Pathol,2013
3. What brown cannot do for you;Rimm;Nat Biotechnol,2006
4. Pathologic complete response to neoadjuvant anti-HER2 therapy is associated with HER2 immunohistochemistry score in HER2-positive early breast cancer;Chen;Medicine (Baltimore),2021
5. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Lamon;N Engl J Med,2009
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Proteomics based selection achieves complete response to HER2 therapy in HER2 IHC 0 breast cancer;npj Precision Oncology;2024-09-14
2. Weakly-supervised deep learning models enable HER2-low prediction from H &E stained slides;Breast Cancer Research;2024-08-19
3. The Performance and Clinical Applicability of HER2 Digital Image Analysis in Breast Cancer: A Systematic Review;Cancers;2024-08-03
4. pH response mechanism of bifunctional fluorescent carbon quantum dots and application in cancer detection and bioself-targeting imaging;Journal of Molecular Structure;2024-07
5. Human epidermal growth factor receptor 2 (HER2) status in breast cancer: practice points and challenges;Histopathology;2024-06-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3